Elena Zamagni is Associate Professor of Hematology at the Bologna University, Italy. She received her medical degree from the University of Bologna, where she also served her residency in haematology. She gained a PhD in Clinical Hematology at the University of Bologna in May 2005. Dr Zamagni’s research interests include areas related to multiple myeloma. She has interests in the role of high dose therapy with stem cell support, prognostic factors, minimal residual disease and in the role of imaging techniques. Dr Zamagni has published over 120 papers in peer-reviewed journals, mainly in the field of plasma cell dyscrasia. She is principal investigator in several national randomized trials in multiple myeloma. Dr Zamagni is an active member of the board of the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) and European Myeloma Network (EMN) working party. She is a member of the Italian Society of Haematology, of the International Myeloma Working Group and of the International Myeloma Society. She has been responsible for the career development committee within the International Myeloma Society since 2019. She has served on the EHA’s Scientific Program Committee since 2017. In addition, Dr Zamagni is part of the editorial board of several hematological journals. She has contributed to the educational session of the Italian Society of Haematology (SIE) and the American Society of Clinical Oncology (ASCO). She is abstracts reviewer for SIE, EHA and ASH.
EM-84196 - Date of preparation: December 2021